Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Introduction: Delayed adjuvant chemotherapy (AC) worsens survival in advanced ovarian cancer (OC), but data on its impact after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is limited. We aimed to assess if delayed AC negatively affects survival in OC patients trea...

Full description

Bibliographic Details
Main Authors: Sergei Iugai, Armando Sardi, Teresa Diaz-Montes, Mary Caitlin King, Vladislav Kovalik, Luis Felipe Falla-Zuniga, Kseniia Uzhegova, Panayotis Ledakis, Carol Nieroda, Vadim Gushchin
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Gynecologic Oncology Reports
Subjects:
Ovarian cancer
Adjuvant chemotherapy
Time to Chemotherapy
Treatment Delays
CRS/HIPEC
Online Access:http://www.sciencedirect.com/science/article/pii/S235257892500030X

Internet

http://www.sciencedirect.com/science/article/pii/S235257892500030X

Similar Items